Login

Debora Cavero

ORCID: 0000-0002-8912-1890
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5114723042
Research Areas
  • Biochemical and Molecular Research
  • DNA Repair Mechanisms
  • CRISPR and Genetic Engineering
  • Chromosomal and Genetic Variations
  • Computational Drug Discovery Methods
  • Ubiquitin and proteasome pathways

Instituto de Investigación de Enfermedades Raras
 2024

Centre for Biomedical Network Research on Rare Diseases
 2024

Instituto de Salud Carlos III
 2024

Universitat Autònoma de Barcelona
 2024

Hospital de Sant Pau
 2024

Institut de Recerca Sant Pau
 2024

 Prognostic significance of mutation type and chromosome fragility in Fanconi anemia
OPENALEX - Publications 
Marı́a José Ramı́rez Roser Pujol Jordi Minguillón Massimo Bogliolo Ilaria Persico and 61 more Debora Cavero Aurora de la Cal Paula Rı́o Susana Navas Navarro José Antonio Casado Almudena Bailador Antonio de la Fuente Miguel López de Heredia F.M. Almazán-Fernández María Luisa Antelo Bienvenida Argilés Isabel Badell Marta Bernués Cristina Beléndez Mar Bermúdez Marta Bernués María Isabel Buedo Estela Carrasco Albert Catalá Dolors Costa Isabel Cuesta Rafael Fernández‐Delgado Ana Fernández‐Teijeiro Á Figuera Marta Rizo García Ainhoa Gondra Macarena González Soledad González Muñiz Inés Hernández‐Rodríguez Fátima Ibáñez Nicholas Kelleher Francisco Lendínez Mónica López‐Duarte Ricardo López Almaraz Inmaculada Marchante Carmen Mendoza J. M. Nieto Emilio Ojeda Salvador Payán‐Pernía Irene Peláez Inmaculada Pérez de Soto Raquel Portugal María A. Ramos‐Arroyo Alexandra Regueiro Ana Rodríguez Jordi Rosell Raquel Sáez González José Luis Sánchez Sánchez Martha Alejandra Morales‐Sánchez M. Leonor Senent Maria C. Tapia Juan Pablo Trujillo‐Quintero José Manuel Vagace Jaime Verdú‐Amorós Victória Verdugo Isabel Vidales Jose Alfredo Carrizalez Villarreal Cristina Díaz de Heredia Julián Sevilla Juan A. Bueren Jordi Surrallés

Abstract Fanconi anemia (FA) is a rare genetic disease characterized by high phenotypic and genotypic heterogeneity, extreme chromosome fragility. To better understand the natural history of FA, identify risk prognostic factors, develop novel therapeutic strategies, Spanish Registry Patients with FA collects data on clinical features, fragility, subtypes, DNA sequencing informed consent participating individuals. In this article, we describe evolution 227 patients followed up for to 30...

10.1002/ajh.27520 article EN cc-by-nc-nd American Journal of Hematology 2024-11-19
Coming Soon ...